Updated September 2026 · Solutions
Add prescription telehealth revenue to your med spa
MyOrbitHealth is the med spa telehealth platform that turns an aesthetics practice into a prescription business without changing who owns it. You keep the spa, the treatment rooms, the brand and the patient list. MyOrbitHealth supplies the clinical layer a med spa cannot build on its own: 2,400+ board-certified providers licensed across all 50 states for good faith exams and follow-ups by video, Orbit Intake for eligibility screening, OrbitRx for EPCS e-prescribing through Surescripts to a LegitScript-certified network of 503A compounding and retail pharmacies, and Orbit Labs for the baseline and recheck panels a GLP-1 or hormone program needs. Patients see your storefront, your subscriptions and your native iOS and Android app, not ours. Providers respond in under six minutes on average during business hours, coverage runs 24 hours, and every contract includes HIPAA and a BAA. The commercial terms are a flat platform fee scoped at onboarding, 0% medication markup, no revenue share, no exit fee and month-to-month after onboarding. Your spa is merchant of record and owns the patients and the data. Programs typically go live in days. This page is general information, not legal or medical advice, and regulatory points are stated as of September 2026.
Who runs what
A med spa that adds telehealth runs two businesses under one brand: the in-office aesthetics practice you already operate, and a remote prescription program. You keep the first. MyOrbitHealth runs the second.
| Brand, storefront and pricing | You: own the brand, pricing, marketing and the patient relationship. / MyOrbitHealth: supplies the branded storefront with checkout and subscriptions and the native iOS and Android app, with no MyOrbitHealth logo in front of the patient. |
|---|---|
| In-office aesthetics | You: keep running injectables, lasers and every service your medical director supervises. / MyOrbitHealth: stays out of the treatment room. |
| Good faith exams | You: decide which services require a GFE. / MyOrbitHealth: routes the patient to an MD, DO, NP or PA licensed in their state for a video exam, documents it and returns the clearance and any patient-specific order to your team. |
| GLP-1, HRT and other take-home programs | You: pick the programs, the product menu and the launch states. / MyOrbitHealth: runs Orbit Intake, the provider visit, the prescription through OrbitRx, pharmacy routing and the follow-up cadence. |
| Labs | You: choose which panels sit on the storefront and whether patients can self-order from the lab catalog. / MyOrbitHealth: Orbit Labs issues provider-ordered requisitions for Quest or Labcorp walk-in, Tasso at-home kits or mobile phlebotomy and routes results to the ordering provider. |
| Pharmacy and fulfillment | You: never handle a take-home prescription. / MyOrbitHealth: sends each patient-specific prescription via Surescripts to a LegitScript-certified 503A compounding or retail pharmacy, cold chain for injectables, shipped to the patient's door. |
| Compliance and credentialing | You: sign the contract and keep marketing claims accurate. / MyOrbitHealth: NCQA-standard credentialing with monthly OIG and SAM screening, SOC 2 Type II, HITRUST-aligned controls, HIPAA plus a BAA, and managed LegitScript certification for your brand. |
What a med spa telehealth program requires, clinically and legally
Remote prescribing adds telehealth practice standards, pharmacy law and federal compounding policy to the medical practice rules a med spa already lives under. The points below reflect the rules as we understand them as of September 2026. They are general information, not legal or medical advice; your counsel and medical director should confirm them for your states.
The good faith exam, and who can perform it
Most states expect a good faith exam before a new patient receives a medical aesthetic treatment, performed by a physician, NP or PA. RNs, aestheticians and medical assistants generally cannot perform it. California's SB 351, effective January 1, 2026, bars RNs from the exam and requires a patient-specific order from a physician, NP or PA. Whether an NP can act alone depends on state practice authority: full-practice states allow it; Georgia, Ohio and Tennessee require a protocol or collaborative agreement with a physician.
Telehealth GFEs are allowed in most states, with conditions
As of September 2026, most states permit the good faith exam by synchronous audio-video telehealth. Texas and Florida tie telehealth GFEs to delegation and prescribing-authority rules; California permits asynchronous questionnaires in some circumstances. The provider must be licensed where the patient is physically located, and the exam must be documented to the in-person standard. MyOrbitHealth applies state rules at intake so a patient in a video-only state is never routed to an asynchronous path.
Medical director and the corporate practice of medicine
Every med spa needs a medical director with an active, unrestricted license in the state where the spa operates. In most states the corporate practice of medicine doctrine bars a non-physician owner from directing clinical care, so non-physician-owned spas typically pair a management services organization with a physician-owned professional entity. Supervision rules vary: Texas requires on-site supervision for lasers, Florida expects the physician to be immediately available, California allows general supervision for delegated injections. Your medical director keeps the in-office role; MyOrbitHealth's providers handle telehealth encounters under the managed-services structure, and your counsel confirms how the two fit.
503A take-home versus 503B office stock
A 503A compounding pharmacy fills a patient-specific prescription and ships it to that patient. It cannot legally supply a shelf of vials for your treatment room. Only an FDA-registered 503B outsourcing facility can compound office stock without a patient-specific prescription, under cGMP and FDA inspection. OrbitRx is the 503A and retail path: a provider writes for a named patient and the pharmacy ships to that patient. Office stock for in-person administration comes through a 503B or manufacturer channel your medical director sources separately.
GLP-1 programs after the shortage
The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage in February 2025; the grace periods for compounded copies ended in spring 2025, and in April 2026 the FDA proposed removing all three GLP-1s from the 503B bulks list. As of September 2026 a med spa semaglutide program cannot be built on mass-compounded copies. It can be built on FDA-approved products and, in narrow cases, on patient-specific compounding where a prescriber documents a legitimate clinical need. Your medical director and the pharmacy decide what is defensible; MyOrbitHealth routes what they approve.
What MyOrbitHealth runs for your med spa program
Everything below is live product. A med spa that signs today typically launches in days, because the provider network, EPCS rails, pharmacy contracts and lab routing already exist and are configured to your brand.
Good faith exams by video, on demand
A new patient books on your storefront or at the front desk. Orbit Intake collects history, allergies, medications and photos, and routes the patient to an MD, DO, NP or PA licensed in their state for a video exam. Providers respond in under six minutes on average during business hours and coverage runs 24 hours, so a walk-in is not turned away. The clearance and any patient-specific order land in OrbitOS for your medical director to review.
GLP-1 weight management as a take-home program
Orbit Intake screens for BMI, comorbidities, contraindications and prior GLP-1 use. A licensed provider reviews the case, orders baseline labs where appropriate, and prescribes through OrbitRx to a LegitScript-certified pharmacy that ships cold chain to the patient. Refills, titration and check-ins run on a subscription cadence inside your app.
Orbit Labs, drawn three ways
A provider orders the panel. The patient collects it as a Quest or Labcorp walk-in with an order slip, a Tasso at-home kit shipped and returned by FedEx, or a mobile phlebotomy visit. Results route to the ordering provider, who reads them into the plan; the patient sees an interpreted result, not a raw PDF. Your storefront can also carry a patient self-order lab catalog.
Provider Network licensed in all 50 states
2,400+ board-certified providers across 38+ specialties, credentialed to NCQA standards with primary-source verification and monthly OIG and SAM screening. Every prescriber who touches a controlled substance has completed EPCS identity proofing and holds a DEA registration.
OrbitRx with EPCS to 503A and retail pharmacies
Prescriptions leave OrbitRx through Surescripts, with EPCS two-factor sign-off where a controlled substance is involved. GLP-1 products, hormone therapies, prescription hair and skin products and ancillaries route to a LegitScript-certified 503A compounding or retail pharmacy, with cold chain for injectables. Medication passes through at 0% markup.
Storefront, app, OrbitOS and developer surface
A branded storefront with checkout and subscriptions, a native iOS and Android app for refills, messaging and results, and OrbitOS as the operator console for encounters, orders, lab status and refill queues. Teams with their own site use the REST API, webhooks and React SDK; a public MCP server lets internal tools query program state. Managed LegitScript certification is included: we prepare, file and manage your brand's application through approval, typically days once filed, with the decision resting with LegitScript.
Economics and where the program can go next
Telehealth revenue is recurring revenue layered on a business that is mostly per-visit. The terms are the same for every brand; the expansion paths are the ones med spa operators most often take.
| Platform fee | A flat platform fee scoped at onboarding based on programs, states and volume. No per-encounter fee, no per-prescription fee and no percentage of revenue. |
|---|---|
| Medication and labs | Medication passes through at 0% markup. Lab pricing is quoted per program at onboarding; there is no published lab rate card. |
| Ownership and exit | Your spa is merchant of record, owns the patients and the data and can export both. No exit fee, month-to-month after onboarding. |
| Start with GFEs | The lowest-lift entry point. Replace an ad hoc per-patient GFE vendor with a network licensed in every state your clients come from. |
| Add GLP-1 weight management | The highest-demand take-home program for spas today, on the same intake, provider pool and pharmacy network, with Orbit Labs for baseline and recheck panels. |
| Add HRT, hair, skin and sexual health | Separate intake and product menu, same stack. Most spas add a second take-home program within the first quarter. Testosterone adds an EPCS and DEA layer the hormone therapy page covers. |
Frequently asked questions
- Can a good faith exam for a med spa be done by telehealth?
- In most states, yes, as of September 2026, provided it is a synchronous video visit with a physician, NP or PA licensed where the patient is located and documented to the in-person standard. Texas and Florida attach delegation and prescribing-authority conditions; California's SB 351 requires a patient-specific order from a physician, NP or PA. This is general information, not legal or medical advice.
- Do I still need my own medical director if I use MyOrbitHealth?
- Yes, for the in-office practice. State law requires a medical director licensed in your state to supervise aesthetic services, and most states' corporate practice rules mean a non-physician owner operates through an MSO paired with a physician-owned entity. MyOrbitHealth's providers handle telehealth encounters under a managed-services structure; your counsel confirms how the two fit.
- Can my med spa offer semaglutide through this platform?
- A GLP-1 program can run on FDA-approved products and, in narrow patient-specific cases, on compounded formulations where the prescriber documents a legitimate clinical reason. As of September 2026 the FDA shortage declarations for semaglutide and tirzepatide have ended and mass compounding of copies is not permitted. A licensed provider decides per patient, and OrbitRx routes the prescription to a LegitScript-certified pharmacy at 0% markup.
- What is the difference between 503A and 503B for a med spa?
- A 503A compounding pharmacy fills a prescription for a named patient and ships it to that patient. A 503B outsourcing facility is FDA-registered and can compound office stock without a patient-specific prescription. OrbitRx is the 503A and retail take-home path. Anything stocked in the treatment room for in-person use comes through a 503B or manufacturer channel your medical director sources.
- How do labs work for a med spa GLP-1 or hormone program?
- A provider orders the panel through Orbit Labs. The patient walks into Quest or Labcorp with an order slip, uses a Tasso at-home kit returned by FedEx, or books mobile phlebotomy. Results go back to the ordering provider, who reads them into the plan. Your storefront can also list a self-order lab catalog. Lab pricing is quoted per program, not published.
Go deeper: what a med spa medical director does, med spa semaglutide programs, how to start a med spa, and 503A vs 503B compounding.
This page is general information, not legal or medical advice.
Add a prescription program to your med spa
Video good faith exams, GLP-1 and HRT take-home programs, Orbit Labs and LegitScript-certified pharmacy routing, all under your spa's brand and live in days.